GGrantIndex
← Leaderboards

Annelise Emily Barron

Northwestern University

Google Scholar ↗PubMed ↗ORCID ↗
$17,092,592
Attributed
$19,901,001
Total exposure
14
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.9M · FY2005–24
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$19,901,001 · 14

By mechanism

R01$8,796,349 · 4
DP1$5,162,184 · 1
RC2$3,590,640 · 2
T32$960,580 · 1
R33$720,489 · 1
R41$256,538 · 1

Top collaborators

Others in their field

Top investigators on “Base”

Research focus

BaseResearch PersonnelIn VivoStructureComplexPeptidesDesignMolecularPathogenSurfaceAdsorptionInfectionGlycineVariantBiomimeticsCellsInvestigationProtocols DocumentationCostSolidFundingAntimicrobialAnalogClinical Trials

Grant awards (53)

Role of Innate Immune Dysregulation in the Etiology of Dementia$1,104,828
DP1 · FY2024 · AG · contact PI
Role of Innate Immune Dysregulation in the Etiology of Dementia$1,104,801
DP1 · FY2023 · AG · contact PI
Role of Innate Immune Dysregulation in the Etiology of Dementia$962,256
DP1 · FY2022 · AG · contact PI
Role of Innate Immune Dysregulation in the Etiology of Dementia$1,026,477
DP1 · FY2021 · AG · contact PI
Synthetic Antimicrobial Peptoids for Treatment of Chronic Suppurative Otitis Media$256,538
R41 · FY2021 · DC
Role of Innate Immune Dysregulation in the Etiology of Dementia$963,822
DP1 · FY2020 · AG · contact PI
Validation and pharmacological profiling of a non-psychoactive THC analog, a novel and selective CB2 receptor agonist, in proof of concept studies using rodent models of heroin addiction$241,871
U18 · FY2020 · DA
Ampetoids as Biostable Functional Mimics of Antimicrobial Peptides$338,008
R01 · FY2011 · AI · contact PI
Ampetoids as Biostable Functional Mimics of Antimicrobial Peptides$91,680
R01 · FY2011 · AI · contact PI
Calvarial Regeneration using Biomatrix-Encapsulated Skeletal Progenitors$1,059,999
RC2 · FY2010 · DE
A Universal Front End to Improve Assembly Outcomes for Next-Gen Sequencing and Re$739,589
RC2 · FY2010 · HG · contact PI
Ampetoids as Biostable Functional Mimics of Antimicrobial Peptides$340,874
R01 · FY2010 · AI · contact PI
Development of a Biomimetic Lung Surfactant Replacement$328,600
R01 · FY2010 · HL · contact PI
Calvarial Regeneration using Biomatrix-Encapsulated Skeletal Progenitors$1,058,384
RC2 · FY2009 · DE
A Universal Front End to Improve Assembly Outcomes for Next-Gen Sequencing and Re$732,668
RC2 · FY2009 · HG · contact PI
Ultrafast DNA sequencing on microfluidic chips: Matrices and mechanisms$466,387
R01 · FY2009 · HG · contact PI
Ampetoids as Biostable Functional Mimics of Antimicrobial Peptides$343,780
R01 · FY2009 · AI · contact PI
Development of a Biomimetic Lung Surfactant Replacement$310,496
R01 · FY2009 · HL · contact PI
Ultrafast DNA sequencing on microfluidic chips: Matrices and mechanisms$477,906
R01 · FY2008 · HG · contact PI
Ampetoids as Biostable Functional Mimics of Antimicrobial Peptides$358,110
R01 · FY2008 · AI · contact PI
Development of a Biomimetic Lung Surfactant Replacement$310,722
R01 · FY2008 · HL · contact PI
Fast Mutation Detection by Tandem SSCP/HA on Microchips$249,018
R33 · FY2008 · CA · contact PI
Ultrafast DNA sequencing on microfluidic chips: Matrices and mechanisms$525,000
R01 · FY2007 · HG · contact PI
Development of a Biomimetic Lung Surfactant Replacement$310,937
R01 · FY2007 · HL · contact PI
Ampetoids as Biostable Functional Mimics of Antimicrobial Peptides$237,938
R01 · FY2007 · AI · contact PI
Fast Mutation Detection by Tandem SSCP/HA on Microchips$173,000
R33 · FY2007 · CA · contact PI
Ampetoids as Biostable Functional Mimics of Antimicrobial Peptides$101,550
R01 · FY2007 · AI · contact PI
Fast Mutation Detection by Tandem SSCP/HA on Microchips$62,554
R33 · FY2007 · CA · contact PI
Development of a Biomimetic Lung Surfactant Replacement$343,280
R01 · FY2006 · HL · contact PI
DNA sequencing by ELFSE on microfluidic devices$328,900
R01 · FY2006 · HG · contact PI
Biotechnology Predoctoral Training Program$303,341
T32 · FY2006 · GM · contact PI
Fast Mutation Detection by Tandem SSCP/HA on Microchips$235,917
R33 · FY2006 · CA · contact PI
THERMO REVERSIBLE GELS FOR MICROCHANNEL SEQUENCING DNA$93,424
R01 · FY2006 · HG · contact PI
DNA sequencing by ELFSE on microfluidic devices$336,815
R01 · FY2005 · HG
Biotechnology Predoctoral Training Program$303,341
T32 · FY2005 · GM
Biotechnology Predoctoral Training Program$50,557
T32 · FY2005 · GM
DNA sequencing by ELFSE on microfluidic devices$336,815
R01 · FY2004 · HG
THERMO REVERSIBLE GELS FOR MICROCHANNEL SEQUENCING DNA$328,663
R01 · FY2004 · HG
Biotechnology Predoctoral Training Program$303,341
T32 · FY2004 · GM
Development of a Biomimetic Lung Surfactant Replacement$220,500
R01 · FY2004 · HL
Symposium on Biological &BioInspired Materials Assembly$16,960
R13 · FY2004 · DE
DNA sequencing by ELFSE on microfluidic devices$348,969
R01 · FY2003 · HG
THERMO REVERSIBLE GELS FOR MICROCHANNEL SEQUENCING DNA$322,431
R01 · FY2003 · HG
Development of a Biomimetic Lung Surfactant Replacement$220,500
R01 · FY2003 · HL
Fast Mutation Detection by Tandem SSCP/HA on Microchips$148,500
R21 · FY2003 · CA
THERMO REVERSIBLE GELS FOR MICROCHANNEL SEQUENCING DNA$316,379
R01 · FY2002 · HG
Development of a Biomimetic Lung Surfactant Replacement$220,500
R01 · FY2002 · HL
THERMO REVERSIBLE GELS FOR MICROCHANNEL SEQUENCING DNA$310,505
R01 · FY2001 · HG
Development of a Biomimetic Lung Surfactant Replacement$220,500
R01 · FY2001 · HL
Symposium on Microscale Separations and Analysis$6,890
R13 · FY2001 · HG
THERMO REVERSIBLE GELS FOR MICROCHANNEL SEQUENCING DNA$231,554
R01 · FY2000 · HG
THERMO REVERSIBLE GELS FOR MICROCHANNEL SEQUENCING DNA$73,247
R01 · FY2000 · HG
THERMO REVERSIBLE GELS FOR MICROCHANNEL SEQUENCING DNA$1,379
R01 · FY2000 · HG